Peter Altman
CIK 1647542 · President and CEO · last filed 2026-07-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$284.0K
Companies
2
Total Filings
116
Lifetime Open-Market Net
$600.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCDA | President and CEO | 368,885 | $0.77 | $284.0K | $354.5K | 69 | 2026-07-20 |
| BioCardia, Inc. (BCDAW) Delisted | President and CEO | 39,445 | $0.01 | $241 | $245.5K | 47 | 2024-07-02 |
Recent Filings · Page 8 of 12
116 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-18 | BioCardia, Inc. (BCDAW) Delisted | Buy (P) | +3,500 | $10.3K | EDGAR |
| 2021-06-11 | BioCardia, Inc. (BCDAW) Delisted | Tax (F) | −11,572 | -$50.3K | EDGAR |
| 2021-04-27 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | −33,581 | $0 | EDGAR |
| 2020-12-01 | BioCardia, Inc. (BCDAW) Delisted | Mixed | +1,000 | $2.7K | EDGAR |
| 2020-11-13 | BioCardia, Inc. (BCDAW) Delisted | Buy (P) | +2,500 | $5.2K | EDGAR |
| 2020-11-12 | BioCardia, Inc. (BCDAW) Delisted | Buy (P) | +2,500 | $5.0K | EDGAR |
| 2020-07-01 | BioCardia, Inc. (BCDAW) Delisted | Tax (F) | −15,159 | -$36.4K | EDGAR |
| 2020-04-28 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | +37,080 | $0 | EDGAR |
| 2020-04-27 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | +400 | $1.4K | EDGAR |
| 2020-03-27 | BioCardia, Inc. (BCDAW) Delisted | Mixed | +7,168 | -$17.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.